There is a significant positive correlation between NMNAT-2 and MARylation levels in the samples of ovarian cancer patients, and a high level of MARylation will lead to poor prognosis with respect to progression free survival (Challa et al., 2021). This evidence concerns the gene NMNAT2 and ovarian cancer.